SCHEMBL1704500

SCHEMBL1704500

CC(C)C(C(C)C)S(=O)(=O)C(C(C)C)C(C)C

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.31
TSHR P16473 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16107041 0.75 ALDH1A1 (0.30) ALDH1A1
SCHEMBL2615551 0.72 KDM4E (0.36) ALDH1A1
SCHEMBL18674543 0.69 CA5A (0.33)
SCHEMBL349157 0.67
SCHEMBL12207180 0.67 CA1 (0.30)
SCHEMBL776749 0.67 ALDH1A1 (0.31) ALDH1A1TSHRHSD17B10
SCHEMBL1705347 0.64
SCHEMBL31231926 0.64 KDM4E (0.33) ALDH1A1
SCHEMBL14775148 0.62
SCHEMBL179829 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250357553-A1 LITHIUM ION SECONDARY BATTERY AND MANUFACTURING METHOD THEREOF LG ENERGY SOLUTION LTD (KR) 2025-11-20 US claimed
EP-4510291-A1 LITHIUM SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR LG Energy Solution, Ltd. (KR) 2025-02-19 EP claimed
WO-2023239074-A1 LITHIUM SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR 주식회사 엘지에너지솔루션 2023-12-14 WO claimed
CN-110349759-B Super capacitor electrolyte and super capacitor 深圳新宙邦科技股份有限公司 2021-11-09 CN claimed
US-20170133716-A1 BATTERY CELL AND BATTERY Lithium Energy and Power GmbH & Co. KG (DE) 2017-05-11 US claimed
EP-3166169-A1 BATTERY CELL AND BATTERY Lithium Energy and Power GmbH & Co. KG (DE) 2017-05-10 EP claimed
US-20250357553-A1 LITHIUM ION SECONDARY BATTERY AND MANUFACTURING METHOD THEREOF LG ENERGY SOLUTION LTD (KR) 2025-11-20 US disclosed
EP-4432389-B1 ELECTRODE AND ELECTRODE ASSEMBLY LG ENERGY SOLUTION LTD (KR) 2025-10-22 EP disclosed
EP-4510275-A1 ELECTRODE ASSEMBLY AND LITHIUM SECONDARY BATTERY COMPRISING SAME LG Energy Solution, Ltd. (KR) 2025-02-19 EP disclosed
EP-4510291-A1 LITHIUM SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR LG Energy Solution, Ltd. (KR) 2025-02-19 EP disclosed
US-20250046948-A1 ELECTRODE ASSEMBLY FOR LITHIUM SECONDARY BATTERY, MANUFACTURING METHOD THEREOF, AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME LG ENERGY SOLUTION, LTD. (KR) 2025-02-06 US disclosed
EP-4503236-A1 ELECTRODE ASSEMBLY AND LITHIUM SECONDARY BATTERY COMPRISING SAME LG Energy Solution, Ltd. (KR) 2025-02-05 EP disclosed
EP-4498468-A1 ELECTRODE ASSEMBLY AND LITHIUM SECONDARY BATTERY LG Energy Solution, Ltd. (KR) 2025-01-29 EP disclosed
WO-2023239074-A1 LITHIUM SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR 주식회사 엘지에너지솔루션 2023-12-14 WO disclosed
WO-2023239128-A1 ELECTRODE AND ELECTRODE ASSEMBLY 주식회사 엘지에너지솔루션 2023-12-14 WO disclosed
WO-2023234684-A1 ELECTRODE ASSEMBLY, METHOD FOR MANUFACTURING SAME, AND LITHIUM SECONDARY BATTERY COMPRISING SAME 주식회사 엘지에너지솔루션 2023-12-07 WO disclosed
US-20170133716-A1 BATTERY CELL AND BATTERY Lithium Energy and Power GmbH & Co. KG (DE) 2017-05-11 US disclosed
EP-3166169-A1 BATTERY CELL AND BATTERY Lithium Energy and Power GmbH & Co. KG (DE) 2017-05-10 EP disclosed
US-20120136175-A1 PROCESS FOR PREPARATION OF ALKYL SULFONE COMPOUNDS SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2012-05-31 US disclosed
EP-2441751-A1 PROCESS FOR PREPARATION OF ALKYL SULFONE COMPOUNDS Sumitomo Seika Chemicals CO. LTD. (JP) 2012-04-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136175-A1 PROCESS FOR PREPARATION OF ALKYL SULFONE COMPOUNDS SULT1A1, CBR1, SULT1E1 ALDH1A1 136/4885TSHR 1331/4885HSD17B10 1323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.